Previous work has shown that intratumoral IFN-β injection-mediated tumor control needed IFNAR in vascular endothelial cells (36), and our work has shown that STING in endothelial cells was critical for IFN-β–induced tumor inhibition. The gene discussed is STING1; the disease is neoplasm.